Literature DB >> 21970410

Molecular analysis of the differentiation potential of murine mesenchymal stem cells from tissues of endodermal or mesodermal origin.

Claudia Concer Viero Nora1, Melissa Camassola, Bruno Bellagamba, Nilo Ikuta, Ana Paula Christoff, Lindolfo da Silva Meirelles, Raquel Ayres, Rogério Margis, Nance Beyer Nardi.   

Abstract

Mesenchymal stem cells (MSCs) have received great attention due to their remarkable regenerative, angiogenic, antiapoptotic, and immunosuppressive properties. Although conventionally isolated from the bone marrow, they are known to exist in all tissues and organs, raising the question on whether they are identical cell populations or have important differences at the molecular level. To better understand the relationship between MSCs residing in different tissues, we analyzed the expression of genes related to pluripotency (SOX2 and OCT-4) and to adipogenic (C/EBP and ADIPOR1), osteogenic (OMD and ALP), and chondrogenic (COL10A1 and TRPV4) differentiation in cultures derived from murine endodermal (lung) and mesodermal (adipose) tissue maintained in different conditions. MSCs were isolated from lungs (L-MSCs) and inguinal adipose tissue (A-MSCs) and cultured in normal conditions, in overconfluence or in inductive medium for osteogenic, adipogenic, or chondrogenic differentiation. Cultures were characterized for morphology, immunophenotype, and by quantitative real-time reverse transcription-polymerase chain reaction for expression of pluripotency genes or markers of differentiation. Bone marrow-derived MSCs were also analyzed for comparison of these parameters. L-MSCs and A-MSCs exhibited the typical morphology, immunophenotype, and proliferation and differentiation pattern of MSCs. The analysis of gene expression showed a higher potential of adipose tissue-derived MSCs toward the osteogenic pathway and of lung-derived MSCs to chondrogenic differentiation, representing an important contribution for the definition of the type of cell to be used in clinical trials of cell therapy and tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21970410      PMCID: PMC3376459          DOI: 10.1089/scd.2011.0030

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  46 in total

1.  Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase.

Authors:  R K Jaiswal; N Jaiswal; S P Bruder; G Mbalaviele; D R Marshak; M F Pittenger
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

Review 2.  Mesenchymal stem cells: paradoxes of passaging.

Authors:  Elisabeth H Javazon; Kirstin J Beggs; Alan W Flake
Journal:  Exp Hematol       Date:  2004-05       Impact factor: 3.084

3.  Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.

Authors:  C K Rebelatto; A M Aguiar; M P Moretão; A C Senegaglia; P Hansen; F Barchiki; J Oliveira; J Martins; C Kuligovski; F Mansur; A Christofis; V F Amaral; P S Brofman; S Goldenberg; L S Nakao; A Correa
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-29

4.  Murine mesenchymal progenitor cells from different tissues differentiated via mesenchymal microspheres into the mesodermal direction.

Authors:  Florian Böhrnsen; Ulrich Lindner; Markus Meier; Abdelalim Gadallah; Peter Schlenke; Hendrik Lehnert; Jürgen Rohwedel; Jan Kramer
Journal:  BMC Cell Biol       Date:  2009-12-19       Impact factor: 4.241

5.  Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation.

Authors:  Yuchang Fu; Nanlan Luo; Richard L Klein; W Timothy Garvey
Journal:  J Lipid Res       Date:  2005-04-16       Impact factor: 5.922

6.  A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties.

Authors:  Erdal Karaöz; Alparslan Okçu; Gülçin Gacar; Ozlem Sağlam; Sinan Yürüker; Halime Kenar
Journal:  J Cell Physiol       Date:  2011-05       Impact factor: 6.384

7.  Osteoclastic activity induces osteomodulin expression in osteoblasts.

Authors:  Ken Ninomiya; Takeshi Miyamoto; Jun-Ichi Imai; Nobuyuki Fujita; Toru Suzuki; Ryotaro Iwasaki; Mitsuru Yagi; Shinya Watanabe; Yoshiaki Toyama; Toshio Suda
Journal:  Biochem Biophys Res Commun       Date:  2007-08-13       Impact factor: 3.575

8.  Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization.

Authors:  Lindolfo da Silva Meirelles; Nance Beyer Nardi
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998

9.  FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling.

Authors:  Tomomi Ito; Rumi Sawada; Yoko Fujiwara; Toshie Tsuchiya
Journal:  Cytotechnology       Date:  2007-10-18       Impact factor: 2.058

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  12 in total

1.  Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification.

Authors:  Indulekha C L Pillai; Shen Li; Milagros Romay; Larry Lam; Yan Lu; Jie Huang; Nathaniel Dillard; Marketa Zemanova; Liudmilla Rubbi; Yibin Wang; Jason Lee; Ming Xia; Owen Liang; Ya-Hong Xie; Matteo Pellegrini; Aldons J Lusis; Arjun Deb
Journal:  Cell Stem Cell       Date:  2016-11-17       Impact factor: 25.269

2.  Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria.

Authors:  Mariana C Souza; Johnatas D Silva; Tatiana A Pádua; Natália D Torres; Mariana A Antunes; Debora G Xisto; Thiago P Abreu; Vera L Capelozzi; Marcelo M Morales; Ana A Sá Pinheiro; Celso Caruso-Neves; Maria G Henriques; Patricia R M Rocco
Journal:  Stem Cell Res Ther       Date:  2015-05-22       Impact factor: 6.832

Review 3.  Multipotent stem cells of the heart-do they have therapeutic promise?

Authors:  Camila F Leite; Thalles R Almeida; Carolina S Lopes; Valdo J Dias da Silva
Journal:  Front Physiol       Date:  2015-05-08       Impact factor: 4.566

4.  Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema.

Authors:  Mariana A Antunes; Soraia C Abreu; Fernanda F Cruz; Ana Clara Teixeira; Miquéias Lopes-Pacheco; Elga Bandeira; Priscilla C Olsen; Bruno L Diaz; Christina M Takyia; Isalira P R G Freitas; Nazareth N Rocha; Vera L Capelozzi; Débora G Xisto; Daniel J Weiss; Marcelo M Morales; Patricia R M Rocco
Journal:  Respir Res       Date:  2014-10-03

5.  Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.

Authors:  Miquéias Lopes-Pacheco; Chiara Robba; Patricia Rieken Macêdo Rocco; Paolo Pelosi
Journal:  Cell Biol Toxicol       Date:  2019-09-04       Impact factor: 6.691

6.  Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans.

Authors:  Sebastio Perrini; Romina Ficarella; Ernesto Picardi; Angelo Cignarelli; Maria Barbaro; Pasquale Nigro; Alessandro Peschechera; Orazio Palumbo; Massimo Carella; Michele De Fazio; Annalisa Natalicchio; Luigi Laviola; Graziano Pesole; Francesco Giorgino
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  Comparison of endometrial regenerative cells and bone marrow stromal cells.

Authors:  Huan Wang; Ping Jin; Marianna Sabatino; Jiaqiang Ren; Sara Civini; Vladimir Bogin; Thomas E Ichim; David F Stroncek
Journal:  J Transl Med       Date:  2012-10-05       Impact factor: 5.531

8.  A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.

Authors:  Flavia Franco Cunha; Leonardo Martins; Priscila Keiko Matsumoto Martin; Roberta Sessa Stilhano; Sang Won Han
Journal:  Stem Cell Res Ther       Date:  2013-07-26       Impact factor: 6.832

9.  Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.

Authors:  Lucas de Mendonça; Nathane S Felix; Natália G Blanco; Jaqueline S Da Silva; Tatiana P Ferreira; Soraia C Abreu; Fernanda F Cruz; Nazareth Rocha; Patrícia M Silva; Vanessa Martins; Vera L Capelozzi; Gizele Zapata-Sudo; Patricia R M Rocco; Pedro L Silva
Journal:  Stem Cell Res Ther       Date:  2017-10-03       Impact factor: 6.832

10.  Evaluation of bone marrow-derived mesenchymal stem cell quality from patients with congenital pseudoarthrosis of the tibia.

Authors:  Ismail Hadisoebroto Dilogo; Fajar Mujadid; Retno Wahyu Nurhayati; Aryadi Kurniawan
Journal:  J Orthop Surg Res       Date:  2018-10-23       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.